HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.

AbstractBACKGROUND:
We investigated the impact of the pre-surgical C-reactive protein-to-albumin ratio (CAR) on survival and recurrence after curative treatment for gastric cancer.
PATIENTS AND METHODS:
This study included 481 patients who underwent curative treatment for gastric cancer between 2013 and 2017. The risk factors for overall (OS) and recurrence-free (RFS) survival were identified.
RESULTS:
A CAR of 0.05 was regarded as the optimal critical point of classification considering the 3- and 5-year survival rates and patients were divided according to their CAR. The OS rates at 3 and 5 years after surgery were significantly higher at 92.5% and 87.9%, respectively, in the low-CAR group compared with 84.9% and 71.9%, respectively, in the high-CAR group. The corresponding RFS rates were 89.1% and 85.5%, and 81.0% and 72.2%, respectively, also a significant difference. A multivariate analysis demonstrated that the CAR was a significant independent risk factor for the OS and marginally significant independent risk factor for the RFS. In addition, the incidences of pancreatic fistula and abdominal abscess were significantly higher and the rate of introduction of adjuvant chemotherapy significantly lower in the high-CAR group.
CONCLUSION:
The CAR was a risk factor influencing survival in patients who underwent curative treatment for gastric cancer. An effective perioperative care plan and surgical strategy need to be developed according to the CAR.
AuthorsToru Aoyama, Masato Nakazono, Kenki Segami, Shinsuke Nagasawa, Kazuki Kano, Takanobu Yamada, Yukio Maezawa, Kentaro Hara, Itaru Hashimoto, Hideaki Suematsu, Hayato Watanabe, Kosuke Takahashi, Masakatsu Numata, Hiroshi Tamagawa, Norio Yukawa, Yasushi Rino, Takashi Ogata, Takashi Oshima
JournalIn vivo (Athens, Greece) (In Vivo) 2021 Nov-Dec Vol. 35 Issue 6 Pg. 3475-3482 ISSN: 1791-7549 [Electronic] Greece
PMID34697184 (Publication Type: Journal Article)
CopyrightCopyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Chemical References
  • C-Reactive Protein
Topics
  • C-Reactive Protein (analysis)
  • Humans
  • Neoplasm Recurrence, Local
  • Prognosis
  • Retrospective Studies
  • Stomach Neoplasms (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: